NCT05767580

Brief Summary

Tests will be performed in individuals with Alzheimer's dementia to compare dual-task and gait with healthy geriatric individuals.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 14, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 21, 2024

Completed
Last Updated

March 14, 2023

Status Verified

March 1, 2023

Enrollment Period

8 months

First QC Date

March 2, 2023

Last Update Submit

March 2, 2023

Conditions

Keywords

dual taskcadancegait speedalzheimer demantia

Outcome Measures

Primary Outcomes (1)

  • Time Up Go

    Timed Start and Continue Test, In the TUG test, individuals stand up from the chair, walk 3 m, walk and sit on a swivel chair. The starting position is standardized with patients feet flat on the floor and their arms resting on the chair. The person is instructed to complete the test at their own pace and as quickly as possible. The test is started with the 'start' command. It ends with him sitting back in the chair. The test is done three times. A 2-minute rest break is given between each trial. The clinician records performance with a stopwatch for each trial.

    6 month

Secondary Outcomes (3)

  • Dual tasking

    6 month

  • Footprint method

    6 month

  • Two-Minute Walk Test

    6 month

Study Arms (2)

alzehimer demantia geriatric

It is a group of individuals over the age of 65, diagnosed with Alzheimer's dementia, able to walk independently, have no communication problems, and volunteer to participate in the research.

Other: evaluation

healty geriatric

This is a group of healthy geriatric individuals over the age of 65 who have not been diagnosed with Alzheimer's dementia, can walk independently, have no communication problems, and volunteered to participate in the study.

Other: evaluation

Interventions

The Timed Get Up and Go test to assess dual-tasking, the 4m Walk Test to assess gait, and the Footprint Method to assess cadence

alzehimer demantia geriatrichealty geriatric

Eligibility Criteria

Age65 Years+
Sexall
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

a total of 50 individuals, including 25 geraitric individuals with Alzheimer's dementia over the age of 65 and 25 healthy geraitric individuals

You may qualify if:

  • years and older,
  • Who volunteered to participate in the research,
  • Able to walk independently,
  • He was diagnosed with Alzheimer's by a physician for the experimental group,
  • Having not been diagnosed with Alzheimer's for the control group
  • Individuals who have not undergone surgery in the last 6 months
  • Individuals who do not have cooperation and communication problems.

You may not qualify if:

  • Under age 65
  • Individuals who do not agree to participate in the research,
  • Individuals who have a disability to do physical activity,
  • Individuals who have undergone an operation in the last 6 months,
  • Individuals with problems of cooperation and communication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

March 2, 2023

First Posted

March 14, 2023

Study Start

June 1, 2023

Primary Completion

February 1, 2024

Study Completion

February 21, 2024

Last Updated

March 14, 2023

Record last verified: 2023-03